Surfactant protein a prevents IFN-γ/IFN-γ receptor interaction and attenuates classical activation of human alveolar macrophages

Journal of Immunology

Volumn 197, Issue 2, 2016, Pages 590-598

  Minutti, Carlos M ^a,b   Garcia Fojeda, Belén ^a,b   Sáenz, Alejandra ^a,b   De Las Casas Engel, Mateo ^c   Guillamat Prats, Raquel ^b,d   De Lorenzo, Alba ^a   Serrano Mollar, Anna ^b,d   Corb, Ángel L ^c   Casals, Cristina ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; RARRES3 PROTEIN; STAT1 PROTEIN; SURFACTANT PROTEIN A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; INTERFERON RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; HUMANS; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERFERON;

EID: 84978136451     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501032     Document Type: Article

References (55)

1. Casals, C., and O. Cañadas. 2012. Role of lipid ordered/disordered phase coexistence in pulmonary surfactant function. Biochim. Biophys. Acta 1818: 2550-2562.
2. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5: 58-68.
3. Coya, J. M., H. T. Akinbi, A. Sáenz, L. Yang, T. E. Weaver, and C. Casals. 2015. Natural anti-infective pulmonary proteins: in vivo cooperative action of surfactant protein SP-A and the lung antimicrobial peptide SP-BN. J. Immunol. 195: 1628-1636.
4. LeVine, A. M., and J. A. Whitsett. 2001. Pulmonary collectins and innate host defense of the lung. Microbes Infect. 3: 161-166.
5. Kopf, M., C. Schneider, and S. P. Nobs. 2015. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16: 36-44.
6. Martinez, F. O., and S. Gordon. 2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6: 13.
7. Murray, P. J., J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14-20.
8. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-g: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
9. Brubaker, S. W., K. S. Bonham, I. Zanoni, and J. C. Kagan. 2015. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33: 257-290.
10. Hu, X., J. Chen, L. Wang, and L. B. Ivashkiv. 2007. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82: 237-243.
11. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNg and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
12. Henning, L. N., A. K. Azad, K. V. Parsa, J. E. Crowther, S. Tridandapani, and L. S. Schlesinger. 2008. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J. Immunol. 180: 7847-7858.
13. Sender, V., L. Lang, and C. Stamme. 2013. Surfactant protein-A modulates LPSinduced TLR4 localization and signaling via b-arrestin 2. PLoS One 8: e59896.
14. Nguyen, H. A., M. V. Rajaram, D. A. Meyer, and L. S. Schlesinger. 2012. Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L608-L616.
15. Arias-Diaz, J., I. Garcia-Verdugo, C. Casals, N. Sanchez-Rico, E. Vara, and J. L. Balibrea. 2000. Effect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages. Shock 14: 300-306.
16. Murakami, S., D. Iwaki, H. Mitsuzawa, H. Sano, H. Takahashi, D. R. Voelker, T. Akino, and Y. Kuroki. 2002. Surfactant protein A inhibits peptidoglycaninduced tumor necrosis factor-a secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2. J. Biol. Chem. 277: 6830-6837.
17. Moulakakis, C., and C. Stamme. 2009. Role of clathrin-mediated endocytosis of surfactant protein A by alveolar macrophages in intracellular signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L430-L441.
18. Crowther, J. E., V. K. Kutala, P. Kuppusamy, J. S. Ferguson, A. A. Beharka, J. L. Zweier, F. X. McCormack, and L. S. Schlesinger. 2004. Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J. Immunol. 172: 6866-6874.
19. Sano, H., H. Sohma, T. Muta, S. Nomura, D. R. Voelker, and Y. Kuroki. 1999. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 163: 387-395.
20. Garc?a-Verdugo, I., F. Sánchez-Barbero, K. Soldau, P. S. Tobias, and C. Casals. 2005. Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein. Biochem. J. 391: 115-124.
21. Yamada, C., H. Sano, T. Shimizu, H. Mitsuzawa, C. Nishitani, T. Himi, and Y. Kuroki. 2006. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization. J. Biol. Chem. 281: 21771-21780.
22. Stamme, C., E. Walsh, and J. R. Wright. 2000. Surfactant protein A differentially regulates IFN-γ? and LPS-induced nitrite production by rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 23: 772-779.
23. Hussain, S., J. R. Wright, and W. J. Martin, II. 2003. Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factora?dependent mechanism. Am. J. Respir. Cell Mol. Biol. 28: 520-527.
24. Pasula, R., J. R. Wright, D. L. Kachel, and W. J. Martin, II. 1999. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J. Clin. Invest. 103: 483-490.
25. Sánchez-Barbero, F., G. Rivas, W. Steinhilber, and C. Casals. 2007. Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization. Biochem. J. 406: 479-489.
26. Sánchez-Barbero, F., J. Strassner, R. Garc?a-Cañero, W. Steinhilber, and C. Casals. 2005. Role of the degree of oligomerization in the structure and function of human surfactant protein A. J. Biol. Chem. 280: 7659-7670.
27. Sáenz, A., A. López-Sánchez, J. Mojica-Lázaro, L. Mart?nez-Caro, N. Nin, L. A. Bagatolli, and C. Casals. 2010. Fluidizing effects of C-reactive protein on lung surfactant membranes: protective role of surfactant protein A. FASEB J. 24: 3662-3673.
28. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, D.C. DOI: 10.17226/5140.
29. Casals, C., J. Arias-Diaz, F. Valino, A. Saenz, C. Garcia, J. L. Balibrea, and E. Vara. 2003. Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L466-L472.
30. Gea-Sorl?, S., R. Guillamat, A. Serrano-Mollar, and D. Closa. 2011. Activation of lung macrophage subpopulations in experimental acute pancreatitis. J. Pathol. 223: 417-424.
31. de las Casas-Engel, M., A. Dom?nguez-Soto, E. Sierra-Filardi, R. Bragado, C. Nieto, A. Puig-Kroger, R. Samaniego, M. Loza, M. T. Corcuera, F. Gómez-Aguado, et al. 2013. Serotonin skews human macrophage polarization through HTR2B and HTR7. J. Immunol. 190: 2301-2310.
32. Green, M. R., and J. Sambrook. 2012. Molecular Cloning: A Laboratory Manual, 4th Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DDC(T)) method. Methods 25: 402-408.
34. Anderson, P., Y. K. Yip, and J. Vilcek. 1982. Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts. J. Biol. Chem. 257: 11301-11304.
35. Sheehan, K. C., J. Calderon, and R. D. Schreiber. 1988. Generation and characterization of monoclonal antibodies specific for the human IFN-γ receptor. J. Immunol. 140: 4231-4237.
36. Vila-del Sol, V., C. Punzón, and M. Fresno. 2008. IFN-γ?induced TNF-a expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J. Immunol. 181: 4461-4470.
37. Fang, F. C. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2: 820-832.
38. Gross, T. J., K. Kremens, L. S. Powers, B. Brink, T. Knutson, F. E. Domann, R. A. Philibert, M. M. Milhem, and M. M. Monick. 2014. Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J. Immunol. 192: 2326-2338.
39. Hussell, T., and T. J. Bell. 2014. Alveolar macrophages: plasticity in a tissuespecific context. Nat. Rev. Immunol. 14: 81-93.
40. Sierra-Filardi, E., C. Nieto, A. Dom?nguez-Soto, R. Barroso, P. Sánchez-Mateos, A. Puig-Kroger, M. López-Bravo, J. Joven, C. Ardav?n, J. L. Rodr?guez-Fernández, et al. 2014. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J. Immunol. 192: 3858-3867.
41. DiSepio, D., C. Ghosn, R. L. Eckert, A. Deucher, N. Robinson, M. Duvic, R. A. Chandraratna, and S. Nagpal. 1998. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc. Natl. Acad. Sci. USA 95: 14811-14815.
42. Carella, C., M. Potter, J. Bonten, J. E. Rehg, G. Neale, and G. C. Grosveld. 2006. The ETS factor TEL2 is a hematopoietic oncoprotein. Blood 107: 1124-1132.
43. Ealick, S. E., W. J. Cook, S. Vijay-Kumar, M. Carson, T. L. Nagabhushan, P. P. Trotta, and C. E. Bugg. 1991. Three-dimensional structure of recombinant human interferon-g. Science 252: 698-702.
44. Ruano, M. L., I. Garc?a-Verdugo, E. Miguel, J. Pérez-Gil, and C. Casals. 2000. Self-aggregation of surfactant protein A. Biochemistry 39: 6529-6537.
45. Wright, J. R. 1997. Immunomodulatory functions of surfactant. Physiol. Rev. 77: 931-962.
46. Ballard, P. L., H. G. Liley, L. W. Gonzales, M. W. Odom, A. J. Ammann, B. Benson, R. T. White, and M. C. Williams. 1990. Interferon-g and synthesis of surfactant components by cultured human fetal lung. Am. J. Respir. Cell Mol. Biol. 2: 137-143.
47. Zhang, S. Y., S. Boisson-Dupuis, A. Chapgier, K. Yang, J. Bustamante, A. Puel, C. Picard, L. Abel, E. Jouanguy, and J. L. Casanova. 2008. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-a/b, IFN-γ, and IFN-l in host defense. Immunol. Rev. 226: 29-40.
48. Ichikawa, A., K. Kuba, M. Morita, S. Chida, H. Tezuka, H. Hara, T. Sasaki, T. Ohteki, V. M. Ranieri, C. C. dos Santos, et al. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am. J. Respir. Crit. Care Med. 187: 65-77.
49. Jiang, D., J. Liang, R. Guo, T. Xie, F. L. Kelly, T. Martinu, T. Yang, A. K. Lovgren, J. Chia, N. Liu, et al. 2012. Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation. Am. J. Respir. Cell Mol. Biol. 46: 592-598.
50. Wang, Z., T. Zheng, Z. Zhu, R. J. Homer, R. J. Riese, H. A. Chapman, Jr., S. D. Shapiro, and J. A. Elias. 2000. Interferon g induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192: 1587-1600.
51. Wang, W., P. Yang, Y. Zhong, Z. Zhao, L. Xing, Y. Zhao, Z. Zou, Y. Zhang, C. Li, T. Li, et al. 2013. Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury. Cell Res. 23: 577-580.
52. Wlodarczyk, M. F., A. R. Kraft, H. D. Chen, L. L. Kenney, and L. K. Selin. 2013. Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A?specific memory T cells. J. Immunol. 190: 2736-2746.
53. Casals, C., A. Varela, M. L. Ruano, F. Valiño, J. Pérez-Gil, N. Torre, E. Jorge, F. Tendillo, and J. L. Castillo-Olivares. 1998. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am. J. Respir. Crit. Care Med. 157: 43-49.
54. Martin, T. R. 2000. Recognition of bacterial endotoxin in the lungs. Am. J. Respir. Cell Mol. Biol. 23: 128-132.
55. Goto, H., J. G. Ledford, S. Mukherjee, P. W. Noble, K. L. Williams, and J. R. Wright. 2010. The role of surfactant protein A in bleomycin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 181: 1336-1344.